The incidence of differentiated thyroid cancer (DTC) has increased in many places around
the world over the past three decades, yet this has been associated with a significant …

Current treatment strategies for pediatric patients with nonmedullary, well-differentiated
thyroid carcinoma (WDTC) are derived from single-institution clinical cohorts, reports of …

Struma ovarii that display extraovarian spread or later recurrence is exceedingly rare.
Among 88 patients with “malignant” struma ovarii followed for prolonged periods, several …

Traditionally, withdrawal of thyroid hormone has been used to attain the increase in serum
TSH concentrations that are believed to optimize the trapping and retention of radioiodine …

Background A 25-year-old woman presented to her gynecologist with pelvic pain. Pelvic
ultrasonography showed a 9 cm left ovarian mass. The patient underwent left oophorectomy …

This chapter reviews how improvements in sensitivity and specificity of thyroid function tests
[total and free thyroid hormones, TSH, thyroid autoantibodies (TRAb, TPOAb and TgAb) and …

Background: To effectively treat differentiated thyroid cancer (DTC) with radioiodine (RAI) it
is necessary to raise serum thyrotropin (TSH) levels either endogenously by thyroid …

Struma ovarii has elicited considerable interest because of its many unique features since
Ludwig Pick first elucidated its relationship to teratoma in the early part of the 20th century. In …

Objective This study tested the hypothesis that administration of human recombinant thyroid-
stimulating hormone (rhTSH: Thyrogen, thyrotropin alpha) could promote iodine-131 ((131) …

We sought to evaluate the efficacy, biochemical effects, safety and outcome of recombinant
human thyroid-stimulating hormone (rhTSH) as an adjunct to radioiodine treatment of …